180 related articles for article (PubMed ID: 23673296)
1. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.
Zhao WY; Wang Y; An ZJ; Shi CG; Zhu GA; Wang B; Lu MY; Pan CK; Chen P
Biochem Biophys Res Commun; 2013 Jun; 435(3):466-71. PubMed ID: 23673296
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.
Ke Y; Zhao W; Xiong J; Cao R
FEBS Lett; 2013 Sep; 587(18):3153-7. PubMed ID: 23954293
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
[TBL] [Abstract][Full Text] [Related]
4. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
7. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
[TBL] [Abstract][Full Text] [Related]
9. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
[TBL] [Abstract][Full Text] [Related]
10. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
Sun Y; Bai Y; Zhang F; Wang Y; Guo Y; Guo L
Biochem Biophys Res Commun; 2010 Jan; 391(3):1483-9. PubMed ID: 20034472
[TBL] [Abstract][Full Text] [Related]
11. MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer.
Chen X; Chen S; Hang W; Huang H; Ma H
Biomed Pharmacother; 2014 Jun; 68(5):589-95. PubMed ID: 24835695
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB.
Yongchun Z; Linwei T; Xicai W; Lianhua Y; Guangqiang Z; Ming Y; Guanjian L; Yujie L; Yunchao H
Cancer Lett; 2014 May; 347(1):65-74. PubMed ID: 24486218
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-429 induces tumorigenesis of human non-small cell lung cancer cells and targets multiple tumor suppressor genes.
Lang Y; Xu S; Ma J; Wu J; Jin S; Cao S; Yu Y
Biochem Biophys Res Commun; 2014 Jul; 450(1):154-9. PubMed ID: 24866238
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level.
Chen S; Wang H; Ng WL; Curran WJ; Wang Y
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1524-9. PubMed ID: 22014955
[TBL] [Abstract][Full Text] [Related]
15. MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1.
Ma Z; Cai H; Zhang Y; Chang L; Cui Y
Biochem Biophys Res Commun; 2017 Aug; 490(2):309-316. PubMed ID: 28619508
[TBL] [Abstract][Full Text] [Related]
16. MiroRNA-188 Acts as Tumor Suppressor in Non-Small-Cell Lung Cancer by Targeting MAP3K3.
Zhao L; Ni X; Zhao L; Zhang Y; Jin D; Yin W; Wang D; Zhang W
Mol Pharm; 2018 Apr; 15(4):1682-1689. PubMed ID: 29528232
[TBL] [Abstract][Full Text] [Related]
17. miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.
Qin Q; Wei F; Zhang J; Wang X; Li B
J Cell Mol Med; 2016 Oct; 20(10):1974-83. PubMed ID: 27241841
[TBL] [Abstract][Full Text] [Related]
18. MiR-195 targets HDGF to inhibit proliferation and invasion of NSCLC cells.
Guo H; Li W; Zheng T; Liu Z
Tumour Biol; 2014 Sep; 35(9):8861-6. PubMed ID: 24891187
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
[TBL] [Abstract][Full Text] [Related]
20. MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.
Li D; Li DQ; Liu D; Tang XJ
Cell Oncol (Dordr); 2016 Apr; 39(2):139-47. PubMed ID: 26744345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
